Rare diseases
Investigational molecules
Locations
Back to Lithuania24 clinical trials in Siauliai, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)LithuaniaLithuaniaLithuaniaLithuaniaLithuaniaLithuaniaLithuaniaLithuaniaLithuaniaLithuaniaLithuaniaLithuaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on cardiovascular disease prevention and treatment, including studies of new medications for stroke prevention and heart attack management.
Groundbreaking research evaluating novel compounds like asundexian and inclisiran for cardiovascular protection.
Comprehensive studies addressing various autoimmune disorders, with particular focus on innovative therapeutic approaches.
Advanced trials testing new biological agents and biosimilars for improved disease control.
Leading-edge research in multiple sclerosis and related neurological conditions, exploring new treatment pathways.
Evaluating innovative medications like remibrutinib and tolebrutinib for enhanced therapeutic outcomes.
Research focusing on lipid disorders and metabolic conditions, investigating novel therapeutic approaches.
Studies evaluating new compounds for managing severe metabolic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
